Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2002, p. 532-538, Vol. 68, No. 2
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.2.532-538.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Syngenta Agribusiness Biotechnology Research Inc., Research Triangle Park, North Carolina 27709,1 Department of Botany and Plant Pathology, Purdue University, West Lafayette, Indiana 479072
Received 21 August 2001/ Accepted 14 November 2001
|
|
|---|
|
|
|---|
Only one of the N. crassa os genes, the os-1 gene (also designated the nik-1 gene), has been identified (1, 30). os-1 encodes a putative two-component histidine kinase that is homologous to the osmosensing Sln1p histidine kinase of Saccharomyces cerevisiae. The osmoregulation mediated by the yeast Sln1p, known as the high-osmolarity glycerol response (HOG), is well characterized (for a review, see reference 11). The major component of the HOG pathway is a mitogen-activated protein (MAP) kinase module consisting of one MAP kinase (Hog1p), one MAP kinase kinase (Pbs2p), and three MAP kinase kinase kinases (Ste11p, Ssk2p, and Ssk22p). The HOG1 MAP kinase can be activated by either of two branches of upstream osmosensing pathways that converge at Pbs2p. One branch involves a two-component histidine kinase phosphorelay system comprised of Sln1p (24), Ypd1p (27), and Ssk1p (17). The other upstream osmosensing branch involves a putative membrane protein, Sho1p, that activates Pbs2p via Ste11p (17, 28). Hyperosmotic stresses activate the HOG pathway, which in turn increases the transcription of key enzymes involved in glycerol synthesis, including glycerol-3-phosphate dehydrogenase (GPD1) and glycerol-3-phosphatase (HOR2). Hyperosmotic stresses also reduce the permeability of the plasma membrane to glycerol, primarily by inhibiting the activity of the Fps1p glycerol transporter. The resulting cytosolic glycerol accumulation leads to increased internal osmolarity and restores the osmotic gradient between the cells and their environment. Yeast mutants defective in HOG1, PBS2, or GPD1 are osmosensitive (12).
Fludioxonil and fenpiclonil are phenylpyrrole fungicides derived from the antibiotic pyrrolnitrin (9, 21). They are broad-spectrum fungicides used to control a variety of important plant-pathogenic fungi. Previous studies with Fusarium sulphureum Schlecht indicated that fenpiclonil inhibited the transport of monosaccharides and caused intracellular accumulation of polyols, such as glycerol and mannitol (13, 14). Wild-type N. crassa strains treated with fenpiclonil and fludioxonil at concentrations that inhibited fungal growth by 50% accumulated high concentrations of intracellular glycerol (26). Some Ustilago maydis and F. sulphureum mutants resistant to phenylpyrrole fungicides also were sensitive to high osmotic pressure (13, 14). These studies suggested that there is a relationship between osmoregulation and phenylpyrrole fungicide resistance.
To determine the relationship between osmoregulation and resistance to phenylpyrrole fungicides in filamentous fungi, in this study we cloned the N. crassa os-2 gene because os-2 mutants are resistant to phenylpyrrole fungicides. The os-2 gene encodes a putative MAP kinase highly homologous to yeast Hog1p. We found that null mutations in os-2 confer resistance to phenylpyrroles but result in sensitivity to high osmotic stresses in N. crassa. In germinating conidia or germ tubes treated with fludioxonil, the fungicide stimulates glycerol accumulation and causes fungal cells to swell and burst. Our data suggest that os-2 is critical for osmoregulation in N. crassa and that phenylpyrrole fungicides may exert their fungicidal effects by interfering with the os-2 MAP kinase pathway.
|
|
|---|
::TRP1) were provided by Michael Gustin of Rice University (Houston, Tex.) and were cultured on YPD (1% yeast extract, 2% peptone, 2% glucose) at 30°C.
N.crassa transformation and sib selection.
N. crassa was transformed as previously described by Vollmer and Yanofsky (33), with the following modification. Instead of using regenerating top agar, we added 5 ml of 1 M sorbitol to the transformation mixture and then poured the mixture onto transformation bottom agar which contained Vogel's medium N supplemented with 2% L-sorbose, 0.05% fructose, 0.05% glucose, 1.5% agar, and an appropriate selection drug (VMSFG agar). The plates were dried with their lids ajar in a biosafety hood for at least 7 h. For sib selection, 228 cosmid clones specific for linkage group IV were propagated individually in 5 ml of Luria-Bertani broth overnight at 37°C. The cultures were combined into 11 pools, and cosmid DNAs were isolated from individual pools. Approximately 3 µg of DNA from each pool was used to transform UCLA80 (os-2). Transformation mixtures were poured onto 20 ml of solidified VMSFG agar containing 100 µg of hygromycin B per ml. After the plates were dry, they were overlaid with 20 ml of VMS agar containing 8% NaCl. We selected for transformants that could grow on VMS medium containing 4% NaCl and 50 µg of hygromycin B per ml since os-2 mutations are recessive and os-2 mutants are sensitive to hypertonic growth conditions (25). Pool 8 contained transformants resistant to 4% NaCl, and DNAs from all 24 cosmid clones in this pool were used to transform UCLA80 (os-2) individually.
Molecular techniques and sequence analysis.
Standard protocols were used for routine molecular manipulations (29). DNA sequences were analyzed with DNASIS V 2.5 for Windows (Hitachi Software Engineering Co., Ltd.). Searches for homologues in DNA and protein sequence databases were performed with the BLAST programs (3). The following primer pairs were used for PCR amplification and sequencing of different regions of the os-2 alleles: HogN14 (5"-AGAGGTATCCGAATTCCCGT-3") and HogC13 (5"-GTGAGGATTGCTGGAAGACG-3"); HogN15 (5"-CACTGAATCAAACCTCGCGT-3") and HogC1 (5"-TGGTTGGTGAGCTGGTCTTT-3"); HogN2 (5"-CTACCTTTGAGATCACCTCG-3") and HogC3 (5"-TGCCAAGTGAGCATGATCTC-3"); HogN4 (5"-TGCGACTTGAAGATTTGCGA-3") and HogC2 (5"-CTTCCATGTGTCGACCGGGAG-3"); and HogN18 (5"-GAGTACCTTGCTCCTTACCA-3") and HogC10 (5"-ATCCTAACCCCAAACATCGC-3").
Construction of an os-2 gene replacement vector and mutant screening.
The os-2 gene replacement vector pYZN16 was constructed with plasmid pBC KS(+) (Stratagene, La Jolla, Calif.) by ligating a 1.8-kb SalI-EcoRI os-2 left flanking fragment, the 1.4-kb hygromycin phosphotransferase gene (hph), and a 1.7-kb HpaI-BamHI os-2 right flanking fragment. Plasmid pYZN16 was used to transform N. crassa wild-type strain 74-OR8-1a. To avoid selecting against os-2 gene replacement transformants, transformation mixtures were incubated at 30°C in regeneration solution (Vogel's medium N supplemented with 2% L-sorbose, 0.05% fructose, 0.05% glucose, and 1 M sorbitol) for 12 h to regenerate cell walls and then plated onto VMSFG agar without any osmotic stabilizer. Hygromycin-resistant transformants were screened for os-2 gene replacement by performing PCR with primers HogN20 (5"-CCCAATTTTCTAGCAAGGG-3") and Hph855R (5"-GCTGATCTGACCAGTTGC-3") and with primers HogC18 (5"-AGTCTTCTGTTGCGCTGTGT-3") and Hph856F (5"-GTCGATGCGACGCAATCGT-3"). These two primer pairs amplify PCR products only in transformants in which there is homologous recombination between pYZN16 and the native os-2 gene, because the sequences of both HogN20 and HogC18 are outside the flanking sequences used to construct the gene replacement vector. Putative os-2 gene replacement isolates were purified by isolation of single conidia and were analyzed further by Southern blot hybridization.
Yeast complementation assay.
The 1.6-kb SacI-KpnI fragment of cDNA clone W08A8 containing the entire os-2 open reading frame was inserted into pYES2 (Invitrogen, Carlsbad, Calif.). The resulting plasmid, pYZN11, was used to transform strains YPH102 and JBY10 with a yeast alkali-cation transformation kit (Bio 101, Inc., La Jolla, Calif.), and the resulting Ura+ transformants were transferred onto YPR (1% yeast extract, 2% peptone, 2% raffinose) agar. After overnight incubation at 30°C, these transformants were inoculated onto YPR agar, YPRG (1% yeast extract, 2% peptone, 1% raffinose, 1% galactose) agar, and YPD (1% yeast extract, 2% peptone, 2% dextrose) agar in the absence or presence of 4% NaCl. Yeast growth was examined after 2 days of incubation at 30°C.
Cytological and biochemical analyses of fludioxonil effects in N.crassa.
Fludioxonil concentrations that resulted in a 50% reduction in growth (IC50) in different N. crassa strains were determined as previously described (26). To study the effect of fludioxonil on conidial germination, N. crassa conidia from wild-type strain 74-OR8-1a and mutant UCLA80 (os-2) were collected from 1-week-old cultures and resuspended at a concentration of 1 x 106 conidia/ml in VMS medium. Fludioxonil was added to each conidial suspension to a final concentration of 0.1, 4, or 81 µM (81 µM was equivalent to 20 ppm of fludioxonil). Since conidial germination was completely eliminated in 74-OR8-1a by treatment with 4 µM fludioxonil, the concentration of fludioxonil was decreased to 0.1 µM in order to observe reduced conidial germination and limited germ tube growth in the wild-type N. crassa strain. Samples were taken at time zero and after 2, 6, 8, and 24 h of fungicide treatment at 30°C and examined for conidial germination and swelling. To study the effect of fludioxonil on hyphal growth, conidial suspensions of wild-type strain 74-OR8-1a and mutant UCLA80 (os-2) containing 1 x 106 conidia/ml were incubated at 30°C for 6 h before fludioxonil was added at final concentrations of 0.1, 4, and 81 µM. Samples were taken at time zero and after 2, 6, 8, and 24 h of fungicide treatment at 30°C and examined for hyphal swelling and bursting. All samples were examined with an Eclipse E600 microscope (Nikon, Melville, N.Y.), and photographs were taken with Kodak Tmax 100 films (Eastman Kodak, Rochester, N.Y.). To study the effect of fludioxonil on the intracellular level of glycerol, N. crassa mycelia were treated with fludioxonil at concentrations of 0.1 µM for wild-type strain 74-OR8-1a (IC50, 0.1 µM), 0.5 µM for Os-2+ transformant YZN61 (IC50, 0.5 µM), and 100 µM for os-2 mutant UCLA80 (IC50, >100 µM) and
os-2 isolate YZN70 (IC50, >100 µM). Glycerol concentrations were determined as described previously (26).
Nucleotide sequence accession number.
The GenBank accession number for the nucleotide sequence of os-2 is AF297032.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Osmotic sensitivity and fungicide resistance of N. crassa os mutants
|
Since the Hog1p MAP kinase plays a key role in the yeast hyperosmotic response, we were interested in examining the function of a homologous N. crassa MAP kinase. A putative yeast HOG1 homologue in the N. crassa EST database generated at the University of New Mexico had been identified previously by a sequence similarity analysis (20). We acquired this cDNA clone, clone W08A8, from the Fungal Genetic Stock Center and used it as a probe to screen the N. crassa pMOcosX cosmid library. Interestingly, cosmid G18G04, the cosmid clone isolated by sib selection for complementing os-2 mutants, was identified as a positive clone with a strong hybridization signal. This led us to speculate that the N. crassa os-2 gene probably encodes a MAP kinase homologous to the yeast Hog1p.
We cloned and sequenced the 3.8- and 2.2-kb SalI fragments that hybridized to cDNA clone W08A8 from cosmid G18G04. Sequence analysis of the genomic and cDNA clones revealed an open reading frame that encoded a protein that was 83% identical and 90% similar to S. cerevisiae Hog1p and 85% identical and 93% similar to Schizosaccharomyces pombe Sty1p. A BsrGI-SacI fragment from the two SalI fragments containing the gene was then cloned into pCB1004 (5). The resulting plasmid, pYZN12, was used to transform os-2 mutant UCLA80. Hygromycin-resistant transformants generated from all three os-2 mutants (Table 1) grew on VMS medium containing 4% NaCl (Fig. 1 and data not shown). These transformants, including YZN61, also became sensitive to fludioxonil upon purification for homokaryons (Fig. 1). Thus, we concluded that the os-2 gene encodes a MAP kinase homologous to yeast Hog1p.
![]() View larger version (116K): [in a new window] |
FIG. 1. Growth of N. crassa os-2 mutants. Fungal growth was examined on VMS medium supplemented with 150 µg of hygromycin B per ml (+Hyg), 4% NaCl (+NaCl), or 81 µM fludioxonil (+Fludioxonil) after 3 days of incubation at 30°C. The strains examined were wild-type (WT) strain 74-OR8-1a, os-2 mutant UCLA80, a transformant of UCLA80 transformed with the wild-type OS-2 gene (YZN1), and an os-2 gene replacement mutant (YZN70).
|
hog1 strain JBY10 and isogenic HOG1 wild-type strain YPH102 (4). URA+ transformants were examined to determine their abilities to grow on both YPD and YPRG agar plates in the presence or absence of 4% NaCl (Fig. 2).
Transformants of JBY10 containing plasmid pYZN11 grew on media containing 4% NaCl, whereas JBY10 itself did not (Fig. 2). Thus, the N. crassa os-2 gene complemented the osmosensitive phenotype of yeast hog1 mutants. Interestingly, even though os-2 expression is under GAL1 promoter control, pYZN11 transformants of JBY10 grew on media containing 4% NaCl and either glucose (repressing conditions) or galactose (inducing conditions) as the carbon source (Fig. 2). These results were confirmed in three independent experiments, suggesting that the low level of expression of N. crassa os-2 under repressing conditions was sufficient to complement the hog1 defect in the yeast for growth on hypertonic medium.
![]() View larger version (63K): [in a new window] |
FIG. 2. Complementation of S. cerevisiae hog1 mutant by the N. crassa os-2 gene. The same yeast strains, including YPH102 (HOG1), JBY10 ( hog1), and YPH102 and JBY10 transformed with the os-2 cDNA construct pYZN11, were used to inoculate YPRG medium (top photograph) and YPD medium (bottom photograph). The YPRG and YPG plates on the right were supplemented with 4% NaCl. The photographs were taken after 3 days of incubation at 30°C.
|
![]() View larger version (18K): [in a new window] |
FIG. 3. Map of the os-2 gene and three os-2 mutant alleles. The 5.98-kb genomic DNA fragment containing the os-2 gene and relevant restriction enzyme sites is shown. The thick line represents the transcribed region, and the potential transcription start site is indicated by an arrow. Introns are indicated by vertical bars. Mutations in the os-2 alleles are indicated by numbers on the map and are described below the map.
|
Effect of fludioxonil on N.crassa conidial and hyphal growth.
We observed that fludioxonil dramatically inhibited conidial germination even at a concentration as low as 0.1 µM in wild-type N. crassa cultures. Untreated conidia germinated after 5 h of incubation (Fig. 4A) and formed hyphae within 24 h, but only short germ tubes were observed in conidia treated with 0.1 µM fludioxonil after 24 h. In conidia treated with higher concentrations of fludioxonil (4 and 81 µM), no germination was observed after 24 h of incubation. Instead, most conidia became swollen, and approximately 80% of the swollen conidia ruptured and released cytoplasmic contents (Fig. 4B). Fludioxonil also caused Botrytis cinerea conidia to burst after 24 h of treatment with a concentration of 4 µM (data not shown). However, conidia from os-2 mutants germinated and grew in VMS medium containing fludioxonil at concentrations up to 100 µM (the highest concentration tested).
![]() View larger version (91K): [in a new window] |
FIG. 4. Effect of fludioxonil treament on N. crassa conidial germination and hyphal growth. (A) Untreated wild-type N. crassa conidia. (B and D) Ungerminated and germinated conidia, respectively, incubated in VMS medium containing 81 µM fludioxonil for 24 h at 30°C. (C) Germ tubes of os-2 mutant UCLA80 incubated in VMS medium containing 81 µM fludioxonil for 24 h at 30°C. Scale bars = 20 µm.
|
Effect of fludioxonil on intracellular glycerol accumulation.
It was reported previously that phenylpyrrole fungicide treatment stimulates glycerol accumulation in wild-type N. crassa strains (26). We measured the glycerol contents in os-2 mutant UCLA80,
os-2 gene replacement strain YZN70, Os-2+ rescued transformant YZN61, and wild-type strain 74-OR8-1a in the presence of 100, 100, 0.5, and 0.1 µM fludioxonil, respectively (Fig. 5).
os-2 mutant UCLA80 and YZN70 accumulated little or no intracellular glycerol in response to fludioxonil treatment, whereas, like the wild type, YZN61 accumulated approximately 50 µg of glycerol per mg (dry weight) of mycelia when it was treated with fludioxonil. This response is similar to the hyperosmotic response in yeast mediated by activation of the Hog1p MAP kinase cascade. Fludioxonil treatment appears to activate the hyperosmotic response in N. crassa, and this activation is mediated by the os-2 MAP kinase.
![]() View larger version (19K): [in a new window] |
FIG. 5. Intracellular glycerol contents of os-2 mutants treated with fludioxonil. All cultures were grown in liquid VMS medium. Fludioxonil was added to final concentrations of 0.1 µM for the wild type, 0.5 µM for os-2+ rescued transformant YZN61, and 100 µM for os-2 mutant UCLA80 and os-2 strain YZN70. Glycerol contents are expressed in micrograms of glycerol per milligram (dry weight [dw]) of mycelia. Symbols: , YZN61; , wild-type strain 74-OR8-1a; , os-2 mutant UCLA80; , YZN70. The symbols indicate means based on three replicates, and the error bars indicate standard errors of the means.
|
|
|
|---|
To further understand the relationship between fungal osmoregulation and fungicide resistance, we cloned the N. crassa os-2 gene. os-2 encodes a MAP kinase homologous to yeast HOG1, which regulates responses, including glycerol accumulation, in yeast cells grown under hypertonic conditions (Fig. 1). Null mutations in os-2 resulted in osmosensitivity and fungicide resistance, and all os-2-associated phenotypes could be restored by reintroducing the wild-type os-2 gene (Fig. 1 and 3). The finding that the os-2 gene replacement transformants were sensitive to 4% NaCl and resistant to fludioxonil confirmed that a functional os-2 gene is essential for osmoregulation and for the fungicidal effect of phenylpyrrole compounds in N. crassa.
We think that N. crassa may have an osmotic response signal transduction pathway similar to that of yeast since os-2 encodes a MAP kinase homologous to yeast HOG1 and os-1 encodes an SLN1-like osmosensing histidine kinase (1, 30). In addition, we have found that os-5 encodes a MAP kinase kinase homologous to S. cerevisiae PBS2 (J.-R. Xu and S. Lam, unpublished data). It is possible that other components of the osmoregulation pathway are encoded by other osmotic loci in N. crassa. However, it should be noted that S. cerevisiae is resistant to both phenylpyrrole and dicarboximide fungicides. Also, deletion of SLN1 is lethal in yeast (18), while N. crassa os-1 deletion mutants are viable (1). These results indicate that there are differences between the N. crassa and yeast osmoregulation pathways, even though many of the components may be conserved.
Fludioxonil treatment of N. crassa wild-type strains causes the conidia and germ tubes to swell and rupture (Fig. 4) and also causes intracellular glycerol to accumulate in the wild-type strain but not in os-2 mutants (Fig. 5) (6). These observations led us to hypothesize that phenylpyrrole fungicides kill fungal cells by overactivating the os-2 osmoregulation pathway. In yeast, hyperactivation of the HOG1 MAP kinase pathway by deletion of its upstream negative regulators SLN1 and YPD1 is lethal (16, 27). The mechanism of the hyperactive lethal effect in yeast (12) and N. crassa is not clear yet, but there are at least two mechanisms that could explain the lethal effect of an overactivated os-2 osmoregulation pathway. One possibility is that intracellular glycerol accumulation caused by fungicide treatment results in extremely high internal turgor pressure and causes fungal cells to swell and rupture. Alternatively, the N. crassa os-2 signal transduction pathway may be involved in other cellular processes, such as cell wall and/or cytoskeleton structure or cell cycle progression. In S. cerevisiae, the HOG pathway has been implicated in regulation of cell wall modification (15) and cytoskeleton reorganization (4) in response to hyperosmotic stresses. The STY1 (HOG1 homologue) MAP kinase pathway of Schizosaccharomyces pombe regulates responses to multiple stresses in addition to hyperosmolarity (11, 33) and has roles in cell cycle control and sexual reproduction (31, 32). In Candida albicans, the MAP kinase homologous to HOG1 is involved in cytokinesis, cell wall metabolism, and dimorphism (2, 34). The N. crassa os-1 gene is involved in hyphal development and regulation of cell wall assembly in response to changes in external osmolarity (1). We noticed in this study that os-2 mutants produced fewer aerial hyphae and conidia on Vogel's medium than the wild-type strains produced. Based on these observations, we think that the osmoregulatory MAP kinase pathway in N. crassa may also have roles in cell wall metabolism and the establishment and elongation of polarized hyphal tip growth. Thus, overactivation of the os-2 pathway by fungicide treatment may lead to a weakened cell wall, abnormal cytokinesis, or aberrant cell cycle control.
Our data are not sufficient to determine whether Os-2 MAP kinase is the direct target of phenypyrrole fungicides. An intracellular cAMP- and calcium-independent protein kinase isolated from N. crassa binds fenpiclonil in vitro (26). However, the identity of this protein kinase and its relationship with the os-2 pathway are unknown. Further characterization of the os-2 signal transduction pathway in N. crassa may help us identify the direct target(s) of phenylpyrrole fungicides. Finally, if our hypothesis that Os-2 is the direct target of phenylpyrrole fungicides is confirmed, this will be the first example of a fungicide that works not by inhibiting an intracellular function or pathway but by overstimulating it.
Journal article no. 16663 of the Purdue University Agricultural Experiment Station. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»